Blood allopregnanolone levels in women with polycystic ovary syndrome

1 Pacini, F., Castagna, M.G., Brilli, L. et al. (2012) Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 23 (Suppl. 7), vii 110–vii 119. 2 Perros, P., Boelaert, K., Colley, S. et al. (2014) Guidelines for the management of thyroid cancer. Clinical Endocrinology, 81 (Suppl. 1), 1–122. 3 Rosario, P.W., Faria, S., Bicalho, L. et al. (2005) Ultrasonographic differentiation between metastatic and benign lymph nodes in patients with papillary thyroid carcinoma. Journal of Ultrasound in Medicine, 24, 1385–1389. 4 Rosario, P.W., Tavares, W.C., Borges, M.A. et al. (2014) Ultrasonographic differentiation of cervical lymph nodes in patients with papillary thyroid carcinoma after thyroidectomy and radioiodine ablation: a prospective study. Endocrine Practice, 20, 293– 298. 5 Scherl, S., Mehra, S., Clain, J. et al. (2014) The effect of surgeon experience on the detection of metastatic lymph nodes in the central compartment and the pathologic features of clinically unapparent metastatic lymph nodes: what are we missing when we don’t perform a prophylactic dissection of central compartment lymph nodes in papillary thyroid cancer? Thyroid, 24, 1282–1288. 6 Kebebew, E., Duh, Q.Y. & Clark, O.H. (2000) Total thyroidectomy or thyroid lobectomy in patients with low-risk differentiated thyroid cancer: surgical decision analysis of a controversy using a mathematical model. World Journal of Surgery, 24, 1295–1302.